Results for tag: "Estrogen Receptor Beta"

The Estrogen Receptor Beta (ER-β) market is a subset of the oncology drug market. ER-β is a type of hormone receptor found in many types of cancer cells, and drugs that target this receptor are used to treat certain types of cancer. ER-β drugs are used to treat breast, prostate, and endometrial cancers, as well as other types of cancer. These drugs work by blocking the action of estrogen, which can help slow the growth of cancer cells. ER-β drugs can also be used to reduce the risk of recurrence in patients who have already been treated for cancer. ER-β drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as chemotherapy or radiation therapy. The ER-β market is a rapidly growing segment of the oncology drug market, as more drugs are developed to target this receptor. Some companies in the ER-β market include AstraZeneca, Pfizer, Merck, and Novartis. Show Less Read more